Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Expert Opinion on Investigational Drugs
|
November 26, 2020
A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects
Min Wu, Jixuan Sun, Dandan Wu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
December 17, 2013
Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells
Yu Peng, Huixiang Yang, Nasui Wang, et al.
Neuroscience Letters
|
January 22, 2009
Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro
Zhengrong Mei, Fangyan Zhang, Liang Tao, et al.
American Journal of Nephrology
|
July 28, 2011
Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation
Qiongjing Yuan, Rui Wang, Yu Peng, et al.
JCI Insight
|
February 29, 2024
HSPA12A maintains aerobic glycolytic homeostasis and Histone3 lactylation in cardiomyocytes to attenuate myocardial ischemia/reperfusion injury
Wansu Yu, Qiuyue Kong, Surong Jiang, et al.
Antimicrobial Agents and Chemotherapy
|
August 21, 2013
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly
Guoyi Wu, Bo Liu, Yingjun Zhang, et al.
Frontiers in Pharmacology
|
February 11, 2021
A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men
Hong Zhang, Hong Wang, Haijing Wei, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 23, 2022
Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial
Min Wu, Xiaojiao Li, Deming Yang, et al.
Environmental Science & Technology
|
April 25, 2025
Air Toxicity Surveillance across Thirteen Cities Using Rats
Chenyu Zhu, Qisong Xing, Huaying Liu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Expert Opinion on Investigational Drugs
|
November 26, 2020
A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects
Min Wu, Jixuan Sun, Dandan Wu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
December 17, 2013
Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells
Yu Peng, Huixiang Yang, Nasui Wang, et al.
Neuroscience Letters
|
January 22, 2009
Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro
Zhengrong Mei, Fangyan Zhang, Liang Tao, et al.
American Journal of Nephrology
|
July 28, 2011
Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation
Qiongjing Yuan, Rui Wang, Yu Peng, et al.
JCI Insight
|
February 29, 2024
HSPA12A maintains aerobic glycolytic homeostasis and Histone3 lactylation in cardiomyocytes to attenuate myocardial ischemia/reperfusion injury
Wansu Yu, Qiuyue Kong, Surong Jiang, et al.
Antimicrobial Agents and Chemotherapy
|
August 21, 2013
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly
Guoyi Wu, Bo Liu, Yingjun Zhang, et al.
Frontiers in Pharmacology
|
February 11, 2021
A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men
Hong Zhang, Hong Wang, Haijing Wei, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 23, 2022
Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial
Min Wu, Xiaojiao Li, Deming Yang, et al.
Environmental Science & Technology
|
April 25, 2025
Air Toxicity Surveillance across Thirteen Cities Using Rats
Chenyu Zhu, Qisong Xing, Huaying Liu, et al.
Page
of 2